The difference between brigatinib and brigatinib

Brigatinib(Brigatinib) and brigatinib are the same drug. Brigatinib is a reversible dual inhibitor of anaplastic lymphoma kinase (ALK) and epidermal growth factor receptor (EGFR). Brigatinib is an anaplastic lymphoma kinase inhibitor used to treat anaplastic lymphoma kinase-positive metastatic non-small cell lung cancer.

Brigatinib is available by prescription only, and treatment must be started and supervised by a doctor experienced in using cancer drugs. Before starting treatment, a patient's cancer should be tested to confirm that it has genetic changes that affect ALK ("ALKpositive" status). This medicine is available as 30 mg, 90 mg, and 180 mg tablets. The recommended starting dose is 90 mg once daily for the first 7 days, increasing to 180 mg once daily thereafter. A dose reduction is recommended in patients with severely reduced hepatic or renal function. Patients with severely reduced kidney function should be closely monitored for symptoms of lung disease such as cough or dyspnea, especially during the first week of treatment. Treatment can continue as long as the patient benefits from it. If side effects occur, your doctor may reduce your dose or temporarily stop treatment. In some cases, treatment should be stopped permanently. Generic drugs of this drug are produced in Laos and Bangladesh, and they are all officially marketed generic drugs. The retail price of Laos United Pharmaceuticals90mg30 capsules900RMB, the retail price of Laos and ASEAN pharmaceuticals90mg21 tablets1900around, the retail price of Bangladesh Beacon Pharmaceutical90mg30 tablets3200around, Bangladesh Yaopin International Pharmaceutical2200around yuan. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.

xa0

xa0